Project Grant R01HL174651
Award Date
9/6/24
Completion Date
6/30/28
Dollars Obligated
$711K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90095, USA
Similar Awards
This $644,687 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research to investigate a neural circuit comprised of orexin neurons, corticotropin-releasing hormone (CRH) neurons, and neurons in the nucleus of the solitary tract. The overarching goal is to understand how this "orexin-CRH-NTS" circuit facilitates the peripheral chemoreflex and contributes to hypertension that...
This federal Project Grant award of $1,704,286 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to uncover the biological basis for why sleep apnea patients are more sensitive to opioid-induced respiratory depression (OIRD), which is a leading cause of death from opioid overdose. The key objectives are to investigate how deficient oxytocin neurotransmission from the paraventricular nucleus of the hypothalamus (PVH)...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $162,728 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the University of California, San Diego (UCSD) for a study focused on cardiovascular outcomes in patients with comorbid obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), known as overlap syndrome (OVS). The 3-year project, running from January 1, 2025 to August 15, 2027, aims to evaluate the underlying...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $740,271 to The Ohio State University to conduct research on the prevalence and under-diagnosis of obstructive sleep apnea (OSA) in primary care clinics. The key products and services to be delivered include: Determining the prevalence of OSA and its subtypes, as well as the rate of under-diagnosis, in primary care practices through...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $1,544,840.00 to Oregon Health & Science University (OHSU) to conduct research on understanding the impact of post-concussive sleep disruption on glymphatic function in collegiate athletes. The study aims to identify risk factors for post-concussive sleep-wake disturbance, establish the combined effects of concussion and sleep...
This Project Grant award of $133,410 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) will support research to investigate the impact of sleep pathology on cardiac aging and cardiovascular disease risk. The project will leverage longitudinal sleep and cardiovascular health data from the Korean Genome and Epidemiology Study (KOGES) to assess how sleep apnea and sleep quality affect cardiac electrophysiological aging over a...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,415,112 project grant under the Cardiovascular Diseases Research program (CFDA 93.837) to the Board of Regents of the University of Nebraska, through its University of Nebraska Medical Center (UNMC) division. The grant aims to evaluate a telehealth-delivered adaptive intervention to promote continuous positive airway pressure (CPAP) therapy adherence and improve health outcomes for adults newly diagnosed with obstructive sleep...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $258,498 will support research to investigate the biological pathways linking sleep health to Alzheimer's disease and cognitive decline. The 5-year project, awarded to the University of California, Los Angeles (UCLA), aims to utilize a multi-omics approach to analyze methylation and metabolomics data associated with short sleep and insomnia, and compare these results to known Alzheimer's...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $115,125 Project Grant (CFDA 93.837 - Cardiovascular Diseases Research) to the University of Miami to investigate the independent and interactive effects of obstructive sleep apnea (OSA) and HIV on ventricular repolarization abnormalities. The project aims to delineate how OSA severity, measured by factors like apnea-hypopnea index and nocturnal hypoxemia, and HIV status impact QT variability index (QTVI), a predictor of ventricular...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $688,800 to the University of Chicago to investigate the role of obstructive sleep apnea (OSA) in glycemic dysregulation among adults with type 1 diabetes. The study aims to determine the extent to which OSA contributes to suboptimal glycemic control in this population, as well as how...